25-Hydroxycholesterol Reprograms Immunosuppressive TAMs
2026-08-13
Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that reinforces tumor-associated macrophage suppression through a GPR155–mTORC1–AMPKα–STAT6 pathway. The study links cholesterol handling to macrophage metabolic state, T-cell surveillance, and anti-PD-1 response, providing a mechanistic framework for studying cold-to-hot tumor conversion.
Epinephrine Bitartrate for Adrenergic Assays
2026-08-12
Epinephrine Bitartrate offers a practical way to stimulate α- and β-adrenergic responses across cardiovascular, airway, immune, and neurobiology models. This guide combines concentration planning, fresh-solution handling, time-resolved assay design, and reference-informed troubleshooting for more reproducible experiments.
NVP-BGJ398 phosphate: FGFR Research Workflows
2026-08-12
NVP-BGJ398 phosphate enables pathway-focused studies across FGFR1–3-driven cancer models and FGFR3-dependent skeletal disease systems. This practical guide covers formulation, phospho-signaling assays, phenotype validation, and troubleshooting for reproducible preclinical experiments.
Prochlorperazine: D2 Antagonist in Research
2026-08-11
Prochlorperazine is a phenothiazine dopamine D2 receptor antagonist used in antiemetic therapy and investigated in melanoma research. Supplier-reported data support defined in vitro concentration windows, melanoma-cell EC50 benchmarks, and mechanistic hypotheses that require validation outside cell culture.
Netarsudil (AR-13324) for Reliable Cell Assays
2026-08-10
This scenario-based guide explains how Netarsudil (AR-13324), SKU B7807, can help researchers distinguish ROCK-driven cytoskeletal effects from genuine viability or cytotoxicity changes. It covers assay design, formulation, controls, data interpretation, siRNA codelivery evidence, and practical product-selection criteria.
Zolmitriptan as a Translational Migraine Probe
2026-08-09
A thought-leadership guide to using Zolmitriptan as a mechanistically anchored 5-HT1B receptor agonist for migraine and cluster headache research, with practical assay design, translational interpretation, and a carefully bounded connection to lysosomal biology.
Live-Dead Cell Staining Kit for Biomaterial Assays
2026-08-08
Learn how Calcein-AM and Propidium Iodide dual staining can quantify cell survival in hydrogel, cytotoxicity, and wound-healing research. This workflow combines microscopy and flow cytometry guidance with practical controls, optimization steps, and troubleshooting for complex biomaterial systems.
BRD4770 and the G9a Logic of Tumor Cell State
2026-08-07
BRD4770 is a G9a histone methyltransferase inhibitor that links H3K9 methylation, senescence, and tumor-cell proliferation. This thought-leadership guide translates evidence from PANC-1 pancreatic cancer models and a BRD4–RAC1 breast cancer study into a practical framework for target validation, assay design, and translational decision-making.
UK-5099 (PF-1005023): Benchmarking Mitochondrial Pyruvate Ca
2026-08-07
UK-5099 (PF-1005023) is a potent, selective inhibitor of the mitochondrial pyruvate carrier, widely employed in mitochondrial metabolism research. It demonstrates strong in vitro and in vivo efficacy, with well-documented impacts on metabolic and immune pathways. The compound’s validated use in standardized immunometabolism protocols provides a robust tool for dissecting metabolic regulation of immune responses.
Estradiol-ERα Inhibition of ER Stress Restores CD4+ T Cells
2026-08-06
This study demonstrates that estradiol, acting through ERα and GPR30, suppresses endoplasmic reticulum stress to restore both proliferation and cytokine production in splenic CD4+ T lymphocytes following hemorrhagic shock. The findings clarify estrogen receptor subtype-specific pathways in immune modulation post-trauma, offering mechanistic insights relevant to research on immune dysfunction, estrogen signaling, and therapy resistance.
O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol
2026-08-06
The referenced study uncovers how Wnt3a signaling promotes bone formation by inducing O-GlcNAcylation, which in turn rewires aerobic glycolysis in osteoblasts. This mechanistic insight highlights O-GlcNAcylation as an indispensable regulator of bone anabolism, offering potential new directions for osteoporosis research.
EdU Imaging Kits (Cy5): Precision S-Phase Tracking in Stem C
2026-08-05
Discover how EdU Imaging Kits (Cy5) empower precise S-phase DNA synthesis measurement in hematopoietic stem cell studies. This article uniquely connects metabolic checkpoint discoveries to practical EdU assay decisions for advanced cell proliferation analysis.
LY2228820 (P38 MAP Kinase Inhibitor): Precision Tools for Pa
2026-08-05
Explore how LY2228820, a potent p38 MAP kinase inhibitor, enables advanced dissection of cellular signaling in inflammation and cancer research. This article offers an in-depth, practical guide to leveraging its selectivity for robust pathway analysis.
Tankyrase Inhibition Modulates Hippo Pathway in HCC Cells
2026-08-04
Jia et al. (2017) demonstrate that tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell growth by modulating the Hippo-YAP signaling cascade. This work reveals a mechanistic link between tankyrase activity, AMOTL1/2 stabilization, and YAP inactivation, highlighting new therapeutic angles for liver cancer research.
KG-501: Precision Disruption of CREB/CBP in Translational On
2026-08-04
Explore how KG-501, a selective CREB-KIX interaction inhibitor, is redefining transcriptional coactivator disruption and epigenetic modulation in translational oncology. This article synthesizes mechanistic insight, experimental protocol guidance, and strategic relevance for researchers aiming to remodel oncogenic signaling and the immune microenvironment in hard-to-treat cancers.
464 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page